ipharmaservicesAug 16, 2019FDA approved AbbVie’s Rinvoq for treatment of moderately to severe rheumatoid arthritis
ipharmaservicesJun 12, 2019US FDA approved Merck's Keytruda for two more target populations in patients suffering from HNSCC